Monkeypox vaccination
Recommendations for the use of pre and post exposure vaccination during a monkeypox incident.
Applies to England
Documents
Details
This document includes information on:
- pre-exposure vaccination for occupational exposure
- post-exposure vaccination
- vaccine prescribing and administration
- consent and record forms
- Imvanex® patient information leaflet
- monkeypox contact tracing classification and vaccination matrix
Further monkeypox guidance can be found on GOV.UK, including information on case definitions.
Last updated 21 May 2022 + show all updates
-
Added links to additional monkeypox guidance.
-
First published.
Update history
2022-08-26 16:31
Added version 12, removed appendices 2 to 5.
2022-08-22 17:53
Updated to include the use of intradermal administration for pre and post-exposure use in healthy adults, limiting post-exposure vaccination to children under 5 and immunosuppressed individuals, during periods of limited supply, and further clarification on vaccine eligibility for occupational exposure.
2022-08-05 16:32
Updated guidance, version 10.
2022-06-17 15:40
Version 9: updated background and added a link to classification of contacts (appendix 6), along with advice for vaccination and follow-up.
2022-06-06 17:41
Updated appendix 6 to clarify recommendations for PEP after 14 days since last exposure.
2022-06-01 19:15
Updated guidance, version 7.
2022-05-27 17:57
Updated guidance, version 6.7.
2022-05-21 15:40
Added links to additional monkeypox guidance.
2022-05-20 17:38
First published.